Microsaic Systems - Notice of AGM
14/11/2024 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241114:nRSN1620Ma&default-theme=true
RNS Number : 1620M Microsaic Systems plc 14 November 2024
14 November 2024
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Notice of Annual General Meeting
Microsaic Systems plc (AIM: MSYS), an international developer and provider of
testing solutions for unique and underserved public health and environmental
markets, announces that its Notice of Annual General Meeting ("Notice of AGM")
is now available on the Company's website at
https://www.microsaic.com/investors/#documents
(https://www.microsaic.com/investors/#documents)
The Notice of AGM will be posted to shareholders today, together with the Form
of Proxy for voting at the Annual General Meeting ("AGM").
The Company will hold its AGM at the offices of Turner Pope Investments (TPI)
Limited (the Company's joint broker) at 3 Queen Street, London, W1J 5PA on 11
December 2024 at noon.
Enquiries:
Microsaic Systems plc +44 (0) 20 3657 0050
Bob Moore, Acting Executive Chairman via TPI
Singer Capital Markets +44 (0)20 7496 3000
(Nominated Adviser & Joint Broker)
Alex Bond / Oliver Platts
Turner Pope Investments (TPI) Limited +44 (0) 20 3657 0050
(Joint Broker)
Andy Thacker / James Pope
About Microsaic Systems
Microsaic is highly experienced in the development, manufacture and supply of
microelectronics instrumentation for markets requiring analytical testing in
public and environmental health markets. The Company has recently acquired and
integrated the assets of Modern Water with Microsaic Systems' technologies
resulting in comprehensive water testing and other toxic testing capabilities.
Microsaic's products and solutions are commercially available through global
markets via a network of regional and country specific distributors and
partners.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOABJBPTMTBBBRI